Prognostic Implications of Myocardial Perfusion Single-photon Emission Computed Tomography in the Elderly
Overview
Authors
Affiliations
Background: The goal of this study was to assess the clinical value of stress myocardial perfusion scintigraphy (MPS) in elderly patients (> or =75 years of age).
Methods And Results: We followed up 5200 elderly patients (41% exercise) after dual-isotope MPS over 2.8+/-1.7 years (362 cardiac deaths [CDs], 7.0%, 2.6%/y) and a subset with extended follow-up (684 patients for 6.2+/-2.9 years; 320 all-cause deaths). Survival modeling of CD revealed that both MPS-measured ischemia and fixed defect added incrementally to pre-MPS data in both adenosine and exercise stress patients. Modeling a subset with gated MPS (n=2472) revealed that ejection fraction and perfusion data added incrementally to each other, further enhancing risk stratification. Unadjusted, annualized post-normal MPS CD rate was 1.3% but <1% in patients with normal rest ECG, exercise stress, or age of 75 to 84 years and was 2.3% to 3.7% in patients > or =85 years of age or undergoing pharmacological stress. However, compared with age-matched US population CD rates (75 to 84 years of age, 1.5%; > or =85 years, 4.8%), normal MPS CD rates were approximately one-third lower than the baseline risk of US individuals (both P<0.05). Modeling of all-cause death in 684 patients with extended follow-up revealed that after risk adjustment, an interaction between early treatment and ischemia was present; increasing ischemia was associated with increasing survival with early revascularization, whereas in the setting of little or no ischemia, medical therapy had improved outcomes.
Conclusions: Stress MPS effectively stratifies CD risk in elderly patients and may identify optimal post-MPS therapy. CD rates after normal MPS are low in all subsets in relative terms compared with the age-matched US population.
Huck D, Divakaran S, Weber B, Brown J, Lopez D, Souza A J Nucl Cardiol. 2024; 40:101908.
PMID: 38996910 PMC: 11527573. DOI: 10.1016/j.nuclcard.2024.101908.
Randazzo M, Elias P, Poterucha T, Sharir T, Fish M, Ruddy T Eur Heart J Cardiovasc Imaging. 2024; 25(7):996-1006.
PMID: 38445511 PMC: 11210974. DOI: 10.1093/ehjci/jeae055.
Gupta S, Sheth S, Kamisetty S, Foreman M, Winchester D J Geriatr Cardiol. 2023; 20(10):760-761.
PMID: 37970229 PMC: 10630167. DOI: 10.26599/1671-5411.2023.10.008.
Kohsaka S, Ejiri K, Takagi H, Watanabe I, Gatate Y, Fukushima K JACC Asia. 2023; 3(1):15-30.
PMID: 36873769 PMC: 9982228. DOI: 10.1016/j.jacasi.2022.10.013.
Multimodality Imaging in Ischemic Chronic Cardiomyopathy.
Muscogiuri G, Guglielmo M, Serra A, Gatti M, Volpato V, Schoepf U J Imaging. 2022; 8(2).
PMID: 35200737 PMC: 8877428. DOI: 10.3390/jimaging8020035.